Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Consensus Recommendation of “Buy” from Analysts

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) has received a consensus recommendation of “Buy” from the eight analysts that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation, one has given a buy recommendation and four have given a strong buy recommendation to the company.

Several equities research analysts have recently issued reports on the stock. Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th. Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. UBS Group upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. HSBC raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Finally, Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th.

Reckitt Benckiser Group Price Performance

OTCMKTS:RBGLY opened at $12.05 on Wednesday. The business’s 50-day moving average is $12.25 and its 200 day moving average is $11.80. Reckitt Benckiser Group has a 12 month low of $10.24 and a 12 month high of $15.03. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.